Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection. Wei L, Wang FS, Zhang MX, Jia JD, Yakovlev AA, Xie W, Burnevich E, Niu JQ, Jung YJ, Jiang XJ, Xu M, Chen XY, Xie Q, Li J, Hou JL, Tang H, Do…

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus. Rupp C, Hippchen T, Neuberger M, Sauer P, Pfeiffenberger J, Stremmel W, Gotthardt DN, Mehrabi A, Weiss KH. World J Gastroenterol. 20…

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US. Des Jarlais DC, Cooper HLF…

Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study. Mabileau G, Scutelniciuc O, Tsereteli M, Konorazov I, Yelizaryeva A, Pop…

Activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in sera of patients with hepatitis C. Jelski W, Strumnik A, Orywal K, Lapinski TW, Swiderska M, Szmitkowski M. Arch Med Sci. 2018 Mar;14(2):281-287. doi: 10.5114/aoms.2016.604…

Transmission genetics of drug-resistant hepatitis C virus. van Buuren N, Tellinghuisen TL, Richardson CC, Kirkegaard K. Elife. 2018 Mar 28;7. pii: e32579. doi: 10.7554/eLife.32579. https://elifesciences.org/articles/32579